Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
AstraZeneca
Pfizer
Charite University, Berlin, Germany
Sun Yat-sen University
Merck Sharp & Dohme LLC
University of Southern California
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Sun Yat-sen University